-
From Biotech to Biopharma: Five companies reshape China's innovative drug landscape with exceeding 10-Billion-Yuan
2026-06-15Ⅰ Chinas Innovative Drug "10-Billion-Yuan Club" officially announced with 5 pharmaceutical companies’ breakthroughIn 2025, five companies—BeOne Medicines, Hengrui Pharma, Sino Biopharma, Hansoh Pharma, and Innovent Biologics—became the first to cross the annual revenue threshold of 10 billion yuan f -
LG Chem's appeal against invalidation of its Chinese patents rejected, Ronbay Technology actively defends itself in international IP challenge
2026-06-15Recently, the Beijing Intellectual Property Court issued a first-instance judgment dismissing the lawsuit filed by South Koreas LG Chem, Ltd. (hereinafter referred to as "LG Chem") concerning two administrative disputes over the invalidation of its Chinese invention patents. The court rejected LG Ch -
China rises to 3rd place in European Patent Applications in 2025
2026-06-15Based on the Technology Board 2025 Report (previously known as the Patent Index) released by the European Patent Office (EPO) on March 24, the EPO received 22,031 patent applications from China in 2025, an increase of 9.7% year-on-year. Chinas total number of patent applications rose to 3rd place fo -
Hytera's eight-year cross-border trade secret litigation concludes
2026-06-15On the evening of March 12th, Hytera (002583.SZ) released an update on a significant legal case, disclosing that the U.S. District Court for the Northern District of Illinois had issued a final judgment in the criminal trade secrets litigation between the company and the U.S. Department of Justice ( -
Interpretation of the IP content of the Supreme People's Court's Work Report: Building a great power of automobile through IP protection
2026-05-081. Data insights: broader coverage and deeper protection offer guidance for automotive industry entitiesIn 2025, there were courts 496,000 intellectual property cases concluded nationwide, representing a 0.3% year-on-year increase despite the large case base. What’s more noteworthy to focus is the l